# EDGAR Filing Document

**Accession Number:** 0001178697
**File Stem:** 0001493152-26-027749
**Filing Date:** 2026-6
**Character Count:** 6057
**Document Hash:** e4d644e59cd66f3a45a675d7b95f15d2
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-26-027749.hdr.sgml**: 20260608

**ACCESSION NUMBER**: 0001493152-26-027749

**CONFORMED SUBMISSION TYPE**: POS AM

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20260608

**DATE AS OF CHANGE**: 20260608

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** DNA X, Inc.
- **CENTRAL INDEX KEY:** 0001178697
- **STANDARD INDUSTRIAL CLASSIFICATION:** TELEPHONE & TELEGRAPH APPARATUS [3661]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 943336783
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** POS AM
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-290589
- **FILM NUMBER:** 261073369

**BUSINESS ADDRESS:**
- **STREET 1:** 4445 EASTGATE MALL
- **STREET 2:** SUITE 200
- **CITY:** SAN DIEGO
- **STATE:** CA
- **ZIP:** 92121
- **BUSINESS PHONE:** 650-378-8100

**MAIL ADDRESS:**
- **STREET 1:** 4445 EASTGATE MALL
- **STREET 2:** SUITE 200
- **CITY:** SAN DIEGO
- **STATE:** CA
- **ZIP:** 92121

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** SONIM TECHNOLOGIES INC
- **DATE OF NAME CHANGE:** 20020724

**As filed with the Securities and Exchange Commission on June 8, 2026**

**Registration No. 333-290589** 

**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**POST-EFFECTIVE AMENDMENT NO. 1 TO** **<br> FORM S-1<br> REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933**

**DNA X, INC.**

**(Exact name of registrant as specified in its charter)** 

---

| | |
|:---|:---|
| **Delaware** | **94-3336783** |
| **(State or other jurisdiction of**<br> **incorporation or organization)** | **(I.R.S. Employer<br> Identification Number)** |

---

**4445 Eastgate Mall, Suite 200**

**San Diego, CA 92121**

**(661) 618-7580**

**(Address, including zip code, and telephone number, including area code, of registrant's principal executive offices)** 

**Clay Crolius**

**Chief Financial Officer**

**DNA X, Inc.** 

**4445 Eastgate Mall, Suite 200**

**San Diego, CA 92121**

**(661) 618-7580**

**(Name, address, including zip code, and telephone number, including area code, of agent for service)** 

*With copies to:* 

**John Egan**

**Justin Anslow**

**Goodwin Procter LLP**

**100 Northern Avenue**

**Boston, Massachusetts 02210**

**(617) 570-1000**

**Approximate date of commencement of proposed sale to the public**: Not applicable

If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933 check the following box: ☐

If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐ Accelerated filer ☐ <br> Non-accelerated filer ☒ Smaller reporting company ☒ <br> Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

**DEREGISTRATION OF SECURITIES**

DNA X, Inc., a Delaware corporation (the "<u>Registrant</u>"), is filing this Post-Effective Amendment No. 1 to the Registration Statement on Form S-1 (File No. 333-290589) (the "<u>Registration Statement</u>") to deregister any and all securities of the Registrant registered but unsold or otherwise unissued under the Registration Statement as of the date hereof.

The Registration Statement pertains to the registration for resale by Chardan Capital Markets, LLC ("<u>Chardan</u>") of up to 350,000,000 shares of the Registrant's common stock, par value $0.001 per share, issuable pursuant to a ChEF Purchase Agreement, dated as of September 29, 2025, by and between the Registrant and Chardan.

Any and all offerings of the Registrant's securities pursuant to the Registration Statement have been terminated. Accordingly, the Registrant hereby terminates the effectiveness of the Registration Statement. In accordance with an undertaking made by the Registrant in the Registration Statement to remove from registration, by means of a post-effective amendment, any of the securities being registered that remain unsold at the termination of the offering, the Registrant hereby removes from registration all securities that were registered but unsold or otherwise unissued under the Registration Statement as of the date hereof.

**SIGNATURES**

Pursuant to the requirements of the Securities Act of 1933, the registrant has duly caused this post-effective amendment to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of San Diego, State of California, on June 8, 2026.

---

| | |
|:---|:---|
| **DNA X, INC.** | **DNA X, INC.** |
| By: | */s/ Clay Crolius* |
| Name: | Clay Crolius |
| Title | Chief Financial Officer |

---

No other person is required to sign this Post-Effective Amendment in reliance upon Rule 478 under the Securities Act of 1933, as amended.